Literature DB >> 8959848

Chronic rejection in lung allografts: immunohistological analysis of fibrogenesis.

T Hirabayashi1, S Demertzis, J Schäfers, K Hoshino, B Nashan.   

Abstract

In ongoing chronic rejection after lung transplantation, alveolar interstitial fibrosis develops. However, little is known about the mechanisms involved. In order to investigate these mechanisms, expression of extracellular matrix molecules (ECM) (undulin, decorin, tenascin, laminin, and fibronectin) and cytokines [transforming growth factor (TGF)-beta 1, TGF-beta 3, platelet-derived growth factor (PDGF), and PDGF receptor] were semiquantitatively evaluated in chronically rejected lung allografts, using standard immunohistochemical techniques. Additionally, the presence of macrophages was analysed. The present study demonstrates an increased infiltration of macrophages with a concomitant upregulation of cytokines (TGF-beta 1, TGF-beta 3, and PDGF) and an increased deposition of ECM in chronic lung rejection. These cytokines have an important role in the stimulation of fibroblasts which are a major source of ECM. Upregulated expression of ECM in the alveolar interstitial space leads to alveolar malfunction by thickening of the wall and, thus, is one of the causative factors of respiratory dysfunction in chronic lung graft rejection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959848     DOI: 10.1007/978-3-662-00818-8_72

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

1.  P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.

Authors:  Fang-Fang Duan; Gabriel Barron; Angelo Meliton; Gokhan M Mutlu; Nickolai O Dulin; Lucia Schuger
Journal:  Am J Respir Cell Mol Biol       Date:  2019-02       Impact factor: 6.914

2.  De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection.

Authors:  Trudie A Goers; Sabarinathan Ramachandran; Aviva Aloush; Elbert Trulock; G Alexander Patterson; Thalachallour Mohanakumar
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

3.  Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Catharina Müller; Annika Andersson-Sjöland; Hans Henrik Schultz; Leif T Eriksson; Claus B Andersen; Martin Iversen; Gunilla Westergren-Thorsson
Journal:  BMJ Open Respir Res       Date:  2017-04-12

4.  Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation.

Authors:  Chetan Naik; Cody Moore; Matthew Pipeling; Jonathan D'Cunha; Kristine Ruppert; Christopher Ensor; Matthew Morrell
Journal:  Transplant Direct       Date:  2018-04-26

5.  Activation of Tissue Remodeling Precedes Obliterative Bronchiolitis in Lung Transplant Recipients.

Authors:  Allan M Ramirez; David R Nunley; Mauricio Rojas; Jesse Roman
Journal:  Biomark Insights       Date:  2008-06-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.